Atossa Genetics: Many American women still not aware of breast cancer risk

Virtually all American women are aware that the pink ribbon is the symbol of breast cancer awareness. Despite this near-universal recognition, it is still a sad fact that plenty of women do not truly appreciate the extent to which they are at risk for breast cancer.

Fresh evidence comes from a recent study by the Mayo Center Clinic for the Science of Health Care Delivery. Researchers found that breast cancer patients in rural areas of the U.S. are less likely than those in cities to receive recommended radiation therapy after having a lumpectomy—a breast-sparing surgery that removes only tumors and surrounding tissue. This is worrisome because lack of follow-up radiation therapy could lead to recurrence and further surgery.

The study also found that rural women were less likely to have their estrogen-receptor status tested and their tumor graded—two important parts of the diagnostic work-up for breast cancer—and were also more likely to choose mastectomy (complete removal of the breast) rather than lumpectomy.

An interesting new approach has been developed by Atossa Genetics, Inc. The ForeCYTE Breast Health Test incorporates the use of an FDA-cleared, patented device, similar to a breast pump in appearance, that collects nipple fluid for testing in women between ages 18 and 73. The collected fluid can be used to identify normal versus premalignant versus malignant cells. The procedure is noninvasive, virtually painless for the patient, and takes about 10 minutes. If necessary, precancerous changes can be addressed with lifestyle intervention or pharmaceutical treatment.

Ultimately, precancerous changes may be treated locally with therapy, also being developed by Atossa. The therapeutic system, which is in the research phase, will provide drugs to be introduced into a "sick duct" and reverse early changes before they become malignant. This technique avoids treating the entire patient with powerful but toxic drugs, instead acknowledging that the problem lies with a milk duct two inches long and the diameter of an angel hair pasta strand.

Source:

Atossa Genetics, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients